Reports

Ideas That Generate Results

List of Figures:

Figure 4-1: Genetic Testing Market (Billion US$), 2013-2018
Figure 4-2: Genetic Testing Market by Geography (%), 2013
Figure 4-3: Number of Companies in Biochemical DTC Genetic Testing Segment (2007-2010)
Figure 4-4: Number of DTC Genetic Testing Companies by Country
Figure 6-1: Number of Disorder, Genes, Labs, & Clinics for Genetic Testing (2013 & 2014)
Figure 6-2: Number of Genetic Tests (2013 & 2014)
Figure 6-3: US - Number of Genetic Tests Available in the Market (2008 & 2012)
Figure 6-4: US - Genetic Testing Equipment Market (Billion US$), 2013-2018
Figure 6-5: Europe - Genetic Testing Equipment Market (Billion US$), 2013-2018
Figure 7-1: Global - Next Generation Sequencing Market (Billion US$), 2013-2018
Figure 7-2: Global - NGS Application by Sector (%)
Figure 7-3: Global - Next Generation Sequencing Market by Player (%), 2012
Figure 7-4: US - Non-Invasive Prenatal Testing Market (Million US$), 2013-2018
Figure 7-5: US - Tapped and Untapped Personalized Cancer WGS Market (%), 2013
Figure 7-6: US - Personalized Cancer WGS Market (Million US$), 2013-2018
Figure 7-7: Organizational Transformation to Support Personalized Medicine
Figure 8-1: Genetic Testing Regulatory Agencies
Figure 9-1: Abbott Laboratories - Revenue Breakup by Geography (%), 2013
Figure 9-2: Abbott Laboratories - Revenue Breakup by Diagnostics Division (%), 2013
Figure 9-3: Roche Holding - Diagnostic Division Revenue by Geography (%), 2013
Figure 9-4: Roche Holding - Revenue Breakup by Business Division (%), 2013
Figure 9-5: Myriad Genetics - Revenue Breakup by Business Segment (%), 2013
Figure 9-6: Life Technologies - Revenue Breakup by Geography (%), 2012
Figure 9-7: Life Technologies - Revenue Breakup by Business Segment (%), 2012
Figure 9-8: Agilent - Revenue Breakup by Business Segment (%), 2013
Figure 9-9: Hologic - Revenue Breakup by Business Segment (%), 2013
Figure 9-10: Hologic - Revenue Breakup by Geography (%), 2013
Figure 9-11: Illumina - Revenue Breakup by Geography (%), 2013
Figure 9-12: Qiagen NV - Revenue Break up by Business Segment (%), 2013
Figure 9-13: Qiagen NV - Revenue Break up by Geography (%), 2013
Figure 9-14: Cepheid - Revenue Break up by Business Segment (%), 2013
Figure 9-15: Cepheid - Revenue Break up by Geography (%), 2013
Figure 9-16: Affymetrix - Revenue Breakup by Geography (%), 2013
Figure 9-17: Affymetrix - Revenue Breakup by Business Segment (%), 2013

List of Tables:

Table 4-1: Key DTC Genetic Testing Companies by Category
Table 4-2: Key Test Areas Offered in DTC Genetic Testing Segment
Table 7-1: FDA Approved Pharmacogenomic Biomarkers for Oncology
Table 9-1: Abbott Laboratories - Key Gene Based Products
Table 9-2: Abbott Laboratories - Financial Performance (Million US$), 2010-2012
Table 9-3: Roche Molecular Diagnostics - Key Gene Based Products
Table 9-4: Roche Holding - Financial Performance (Million CHF), 2011-2013
Table 9-5: Myriad Genetics - Key Gene Based Products
Table 9-6: Myriad Genetics - Financial Performance (Million US$), 2011-2013
Table 9-7: Life Technologies - Key Gene Based Products
Table 9-8: Life Technologies - Financial Performance (Million US$), 2010-2012
Table 9-9: Agilent - Key Gene Based Products
Table 9-10: Agilent - Financial Performance (Million US$), 2011-2013
Table 9-11: Hologic - Key Gene Based Products
Table 9-12: Hologic - Financial Performance (Million US$), 2011-2013
Table 9-13: Illumina - Key Gene Based Products
Table 9-14: Illumina - Financial Performance (Million US$), 2011-2013
Table 9-15: Qiagen NV - Key Gene Based Products
Table 9-16: Qiagen NV - Financial Performance (Million US$), 2011-2013
Table 9-17: Cepherid - Key Gene Based Products
Table 9-18: Cepheid - Financial Performance (Million US$), 2011-2013
Table 9-19: Affymetrix - Key Gene Based Products
Table 9-20: Affymetrix - Financial Performance (Million US$), 2011-2013